1 / 20

Overview of Investigational Drug Services and Study Drug Accountability

Overview of Investigational Drug Services and Study Drug Accountability. Merrell Lim, Pharm.D. Investigational Drug Services Pharmacist mlim1@clarian.org 317-944-1900. Learning Objectives. Learn about services provided by investigational drug services (IDS) pharmacy

lieu
Télécharger la présentation

Overview of Investigational Drug Services and Study Drug Accountability

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Overview of Investigational Drug Services and Study Drug Accountability Merrell Lim, Pharm.D. Investigational Drug Services Pharmacist mlim1@clarian.org 317-944-1900

  2. Learning Objectives • Learn about services provided by investigational drug services (IDS) pharmacy • Understand the role of IDS staff • Learn about importance of drug accountability • Gain further understanding of operations within the IDS pharmacy

  3. Investigational Drug Services (IDS) • IDS Pharmacy: • Coordinate Phase I to Phase IV studies • Commercially available and investigational agents • Drug accountability, record keeping, study procedures • IDS hours • 8:00 a.m. ~ 4:30 p.m. • Monday to Friday • IDS Location: • IU Simon Cancer Center Room C2102 • IDS Staff: • Three full-time pharmacists • Four pharmacy technicians

  4. Investigational Drug Services (IDS) • Responsibilities of IDS Pharmacists: • Review study protocols • Participate in ‘study start-up activities’ • Write study procedures • Verify study drugs prepared by IDS technicians • Participate as reviewer for IRB Committee • Responsibilities of IDS technicians: • Drug preparation • Drug procurement (ordering, returns, inventory management) • Study monitor guidance • Study billing

  5. Investigational Drug Services (IDS) • Drug accountability involves: • Drug procurement • Drug and patient specific logs • Control site VS. Satellite site • Storage • Drug packaging/Blinding • Randomization • Labeling • Drug dispensing • Drug returns

  6. Study Drug Procurement • Study drugs can be obtained from: • Research organization • Study company • Methods • Company order sheets • Phone calls • Interactive Voice Response System (IVRS) • Study drugs not ordered in bulk

  7. Study Drug Accountability Logs • Drug accountability logs • Completed with each study drug transaction • Completed at time of study drug receipt or dispensing • Patient specific logs • Used in addition to the ‘Drug Accountability Logs’ • Tear off labels • Affixed to specific patient log to track study drug dispensing

  8. Transferring Study Medications

  9. Study Drug Storage • IDS storage area for: • Study binders • Study drugs • Study drug returns • Study drugs stored specific to drug product: • Room temperature/Refrigerator/Freezer • Light Sensitivity • Items arranged by IRB# assigned

  10. Study Drug Packaging/Blinding • Pharmacy blinded • Study drug name/placebo • Bottle/vial number • IVRS needed to assign drug/placebo to patient • Pharmacy unblinded • Active drug and placebo shipped separately • IVRS or randomization chart needed to assign study drug/placebo to patient

  11. Study Drug Packaging/Blinding • Breaking the blind • Principle investigator is the only person to break blind • AVOID breaking blind if possible • If treating adverse reactions, treat subject as if on active drug

  12. Study Drug Randomization • Methods of randomizing patients • Randomized by research RN (at screening) • Pre-printed randomization lists • Sealed envelopes • Interactive Voice Response System (IVRS)

  13. Study Drug Labeling • IDS Pharmacy labeling • Drug name • Listed as “Study drug/placebo” • IRB # • Study Protocol # • Drug formulation • Quantity • Hospital name and address

  14. Study Drug Dispensing • Patient specific log filled out • Research RN picks up study medications • No counseling from IDS about study medications • Returning containers • Educate patients on adherence issues

  15. Return of Drug Supply • Visits by study monitor • Reviewing of accountability logs • Destroying study medications on site • Returning supply to study sponsor • Check and see what sponsor requires

  16. Overview of IDS Procedures • Prepare budget for study (pharmacy portion) • Attend IRB meeting to have study approved • Build study product in Cerner • Attend start up meeting • Write study procedures

  17. Overview of IDS Procedures • Create and build order sets • Have order sets approved • Print copies of procedures and study logs and have technician create study binder • Document all shipping and correspondence in file cabinet

  18. Overview of IDS Procedures • Checking study drug product • Documenting study drug usage in accountability logs • Accommodating monitor visits • Close out studies that are completed • Billing issues

  19. IDS Pharmacy Staff Contact information • IDS website: www.clarian.org/investigationaldrugservices • IDS Pharmacists: • Bonnie Klank, Pharm.D. (bklank@clarian.org) • Edward Leung, Pharm.D. (leunge@clarian.org) • Merrell Lim, Pharm.D. (mlim1@clarian.org) • IDS Technicians: • Denise Cox (dccox@clarian.org) • Ronda Murphy (rmurphy@clarian.org) • Jan Pfeiffer (jpfeiffe@clarian.org) • Jada Weger-Effinger (jwegere1@clarian.org)

  20. Questions?

More Related